Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd)

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.070
https://www.valueinhealthjournal.com/article/S1098-3015(15)02146-4/fulltext
Title : Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02146-4&doi=10.1016/j.jval.2015.09.070
First page : A881
Section Title : Research Podium Presentations - Session 1
Open access? : No
Section Order : 2823
Categories :
Tags :
Regions :
ViH Article Tags :